Related Experiment Video
Updated: Jun 20, 2026

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference
Bin Xie1, Renxin Xing, Ping Chen
1Department of Hepatobiliary Surgery, Daping Hospital and the Field Surgery Research Institute, Third Military Medical University, Chongqing, China.
Background:
Cell migration is a basis for invasion and metastasis of malignant tumors. Receptor tyrosine kinases are recognized as important therapeutic targets in antineoplastic strategies. C-met is a receptor tyrosine kinase highly expressed in human hepatocellular carcinoma (HCC) cell line MHCC97-H. Higher expression of c-met in tumor tissue can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventually, metastasis. To explore the roles of c-met in modulating the motility of cell, we silenced c-met expression in the HCC line MHCC97-H by RNA interference (RNAi).
Materials And Methods:
For transient expression, c-met-siRNA 1,2 recombinant plasmids were transfected into phoenix A cells. The MHCC97-H cells were cultured in Dulbecco's modified Eagles's medium (DMEM) with 10% fetal bovine serum (FBS) to establish MHCC97-H HCC cells stably expressing c-met-siRNA. MHCC97-H cells were treated with the recombinant virus for assay of c-met mRNA and protein, evaluation of growth and invasion of MHCC97-H cells, and identification of hepatitis B virus X (HBX) protein correlation with c-met.
Results:
After transfection of c-met-siRNA for 48 h, the expression of c-met decreased markedly in MHCC97-H cells; the most effective site of the siRNA target sequence is at the 537 upstream, far from the transcription start. In addition, the proliferation, motility, and invasive ability of MHCC97-H cells were significantly inhibited. Furthermore, we showed that hepatitis B virus (HBV) X protein (HBX) potentiated the activities of the extracellular signal-regulated kinase 1/2 (ERK1/2) in MHCC97-H cells. Treatment with extracellular signal-regulated kinase (ERK) inhibitor (U0126), but not P38 MAPK inhibitor (SB203580) or phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin), markedly suppressed the expression of c-met protein in MHCC97-H cells.
Conclusion:
These results indicate that the over-expression of c-met protein plays an important role in the cell invasion of MHCC97-H, and HBX protein may promote the expression of c-met by ERKs pathway.
Insights
Silencing c-met expression in hepatocellular carcinoma (HCC) cells significantly inhibited proliferation and invasion. Hepatitis B virus X protein may promote c-met expression via the ERK pathway, highlighting c-met as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Cell migration is fundamental to malignant tumor invasion and metastasis.
- Receptor tyrosine kinases, like c-met, are key therapeutic targets in cancer.
- C-met is highly expressed in hepatocellular carcinoma (HCC) MHCC97-H cells, correlating with increased motility and invasion.
Purpose of the Study:
- To investigate the role of c-met in modulating cell motility in HCC.
- To silence c-met expression in MHCC97-H cells using RNA interference (RNAi).
Main Methods:
- MHCC97-H cells were stably transfected with c-met-siRNA.
- Assays were performed to evaluate c-met mRNA and protein levels, cell growth, and invasion.
- Correlation between hepatitis B virus X (HBX) protein and c-met was investigated.
Main Results:
- C-met expression was significantly reduced in MHCC97-H cells after c-met-siRNA transfection.
- Cell proliferation, motility, and invasion were markedly inhibited.
- Hepatitis B virus X (HBX) protein potentiated extracellular signal-regulated kinase 1/2 (ERK1/2) activity, and ERK inhibition suppressed c-met protein expression.
Conclusions:
- Over-expression of c-met protein is crucial for MHCC97-H cell invasion.
- HBX protein may enhance c-met expression through the ERK signaling pathway.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Regulation of Expression at Multiple Steps
